Corteva (CTVA) Q1 2026 Earnings
Reported May 5, 2026 at 4:41 PM ET · SEC Source
Q1 26 EPS
$1.50
BEAT +27.11%
Est. $1.18
Q1 26 Revenue
$4.91B
BEAT +5.77%
Est. $4.64B
vs S&P Since Q1 26
+1.4%
BEATING MARKET
CTVA +2.9% vs S&P +1.5%
Market Reaction
Did CTVA Beat Earnings? Q1 2026 Results
Corteva kicked off 2026 with a convincing first-quarter beat, posting non-GAAP operating EPS of $1.50 against a consensus estimate of $1.18, a 27.11% beat, while revenue of $4.91 billion topped expectations by 5.77% and climbed 11.1% from a year ago.… Read more Corteva kicked off 2026 with a convincing first-quarter beat, posting non-GAAP operating EPS of $1.50 against a consensus estimate of $1.18, a 27.11% beat, while revenue of $4.91 billion topped expectations by 5.77% and climbed 11.1% from a year ago. The primary engine behind the strong print was the Seed segment, where net sales rose 12% year-over-year to $3.02 billion, led by 15% growth in corn seed to $2.37 billion, with volume gains, favorable pricing mix, and currency tailwinds all contributing to a 23% jump in Seed operating EBITDA and roughly 310 basis points of margin expansion. Crop Protection also contributed meaningfully, with herbicides surging 19% to $1.03 billion and overall segment sales up 10%. Looking ahead, Corteva reaffirmed full-year 2026 guidance of $3.45 to $3.70 in operating EPS and $4.00 billion to $4.20 billion in operating EBITDA, even as investor attention increasingly shifts toward the company's planned Q4 2026 separation into two independent entities, Vylor and New Corteva.
Key Takeaways
- • Seed price/mix gains in all regions from price-for-value strategy and favorable product mix
- • Volume growth in North America driven by seasonal timing shifts in seed deliveries
- • Crop Protection volume improvement driven by demand for new products and spinosyns
- • Disciplined cost management and productivity savings across both segments
- • Favorable currency impacts led by the Euro and Brazilian Real
- • Seed operating EBITDA margin expansion of approximately 310 basis points
- • Crop Protection operating EBITDA margin expansion of approximately 100 basis points
CTVA Forward Guidance & Outlook
Corteva reaffirmed full-year 2026 guidance with Operating EBITDA expected to be $4.0 billion to $4.2 billion (7% growth at the mid-point) and Operating EPS of $3.45 to $3.70 per share (7% growth at the mid-point). The company expects the net impact from geopolitical and trade developments to be manageable within current guidance. In Seed, continued demand for technology-driven offerings is expected, supported by product innovation and a solid Northern Hemisphere planting season. In Crop Protection, volume growth is anticipated driven by differentiated solutions with improving supply-demand dynamics. The company plans to repurchase approximately $500 million of shares during the first half of 2026. The separation into two companies remains on track for Q4 2026, with one-time separation costs expected to be approximately $350 million and net dis-synergies of approximately $100 million trending favorably.
CTVA YoY Financials
Q1 2026 vs Q1 2025, source: SEC Filings
CTVA Revenue by Segment
With YoY comparisons, source: SEC Filings
CTVA Revenue by Geography
With YoY comparisons, source: SEC Filings
“In the first quarter, Corteva delivered a strong start to the year, delivering growth across both businesses and all regions. Our performance reflects a solid start to the season in the Northern Hemisphere coupled with disciplined cost management and continued demand for our advanced technology, all of which allowed us to deliver earnings growth and margin expansion. We also made good progress on our separation, naming executive leadership teams for both future companies, filing our initial Form 10, and announcing Vylor, the new name for our future advanced seed and genetics company. We remain focused on launching two strong companies, on track for the fourth quarter, and on delivering our 2026 targets. Our future is bright.”
— Chuck Magro, Q1 2026 Earnings Press Release
CTVA Earnings Trends
CTVA vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
CTVA EPS Trend
Earnings per share: estimate vs actual
CTVA Revenue Trend
Quarterly revenue: estimate vs actual
CTVA Quarterly Results
4 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 BEAT | $1.18 | $1.50 | +27.11% | $4.91B | +5.77% |
| Q4 25 BEAT FY | $0.22 | $0.22 | +1.76% | $3.91B | -7.49% |
| FY Full Year | — | $3.34 | — | $17.40B | — |
| Q3 25 BEAT | $-0.47 | $-0.23 | +50.61% | $2.62B | +6.10% |
| Q2 25 BEAT | $1.88 | $2.20 | +17.09% | $6.46B | +2.97% |